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the techniques described here to achieve better tumor control, increase procedure safety 
and improve patient selection. It is also very important to increase awareness about 
interventional radiology procedures among medical oncologists and other medical 
specialists involved in the management of the patients with metastatic colorectal 
cancer so that the patients could be more often referred to interventional radiology. 
Minimally invasive procedures have many advantages over traditional treatments, 
including lower morbidity and mortality, also sometimes representing the patients an 
only viable treatment option. 
Colorectal cancer patients with metastatic disease could benefit from this thesis 
in multiple ways. Currently there is a lack of awareness among the patients about 
interventional radiology [8]. This may result in patients favoring traditional therapies 
over unfamiliar minimally invasive procedures despite lower complication rates, faster 
recovery time and a better quality of life. There is evidence that the patients referred for 
an interventional radiology procedure largely do not know very much if anything about 
the field, even if they had undergone an interventional radiology procedure in the past 
[8]. Efforts to increase public awareness about this field could improve patient access 
to these procedures and empower patients with the information they need to make the 
best healthcare decisions themselves. 
The patients with other types of oligometastatic cancer also could benefit from our 
research as the interventional radiology procedures we described are used for multiple 
types of oligometastatic cancer.
Researchers, conducting clinical and fundamental research in interventional radiology, 
colorectal cancer as well as in other local therapies could also find this thesis useful. 
Multidisciplinarity and combinational treatments are very important to maximize 
treatment outcomes in the patients with metastatic CRC.
INNOVATION AND FUTURE
The results of this thesis demonstrated that it is possible to achieve better local tumor 
control with thermal ablation while creating a sufficient minimal ablation margin 
[9]. We also identified complications risk factors following thermal ablation and 
provided recommendation on how to approach high-risk patients [10]. In terms of 90Y 
radioembolization approaches, we developed a prognostic tool aimed at improving 
patient selection [11] as well as proposed a modified 90Y resin microspheres infusion 
Colorectal cancer (CRC) is one of the deadliest cancers, with metastatic disease being 
the most common cause of death in these patients [1]. Netherlands is among top ten 
countries in the world with the highest CRC prevalence [2]. On a daily basis around 37 
patients receive CRC diagnosis and 14 patients die from CRC in the Netherlands [3]. 
The incidence of CRC is expected to rise even further because of the implementation 
of nationwide screening program [4] growing incidence in rectal cancer among young 
patients [5-7] and ageing population.
To date, the awareness of general population, patients and referring physicians about 
the field of interventional oncology and what it has to offer for the patients with CRC 
is low [8]. Thus active participation of those in the field is crucial to help to educate the 
public about many potential benefits interventional radiology may offer. 
RELEVANCE
With this thesis, we aimed to provide an overview about the expanding role of 
interventional oncology in the management of the patients with metastatic CRC. We 
provided the data on oncological outcomes following the most common as well as 
emerging interventional oncology procedures. These procedures included thermal 
ablation (in the liver and lungs) and 90Y radioembolization approaches. Notably, we 
analyzed predictive and prognostic factors for local tumor control, safety and survival 
following these therapies. 
The research presented in this thesis was performed within the collaborative research 
project between the Netherlands Cancer Institute and Memorial Sloan Kettering Cancer 
Center (New York, USA). Memorial Sloan Kettering Cancer Center performs one of the 
largest numbers of interventional oncology procedures in the world, which enables to 
conduct large scale laboratory and clinical research. This collaboration was formed in 
order to profit from the expertise which is present there in the area of most modern 
minimally invasive approaches for the treatment of metastatic colorectal cancer and 
transfer this knowledge to the Netherlands. 
TARGET POPULATION
This thesis has a wide target population. It includes interventional radiologists who are 
utilizing these procedures in their daily practice and who could benefit from applying 
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technique to improve the procedure safety [12]. We also filled in the knowledge gap 
on radiation segmentectomy for the patients with liver metastatic disease and limited 
treatment options, demonstrating that it has a potential to safely achieve high tumor 
response and local tumor control rate. 
Currently minimal ablation margin assessment is not performed universally and 
uniformly among interventional radiologists immediately post-procedure. Ablative 
dose radioembolization approaches, such as radiation segmentectomy are emerging, 
but are also not yet utilized in multiple centers due to the limited evidence available 
to date. There is a lack of prognostic tools for physicians to use during pre-procedure 
patient visit to help decision-making. Our research tried to address all these limitations; 
however larger prospective trials, aiming at externally validating our retrospective 
study results are warranted.
In addition, despite expanding evidence regarding the value of interventional oncology 
procedures to provide local disease control, data on the effect of these procedures 
on patients’ overall survival is lacking. Prospective studies comparing different 
locoregional modalities to surgery are also limited. Future research should also 
focus on the identification of the patients with curable oligometastatic CRC disease, 
systemic effects of interventional radiology procedures and immunomodulation. As 
interventional oncology techniques strive to take additional roles in the management 
of the patients with metastatic CRC, progress will ultimately depend on the ability to 
produce substantial prospective trial-based evidence.
228 229
11 11
VALORIZATIONPART 3 | CHAPTER 11
